More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque psoriasis, Artax Biopharma announced in a press release.

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

That’s because certain genes play a role. Psoriasis is a skin disease that affects about 8 million Americans. It comes in several forms. Plaque psoriasis is the most common. Plaque psoriasis ...

Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...

Sotyktu (deucravacitinib) is a brand-name oral tablet that’s prescribed for plaque psoriasis in certain adults ... who took Sotyktu in clinical trials: Mild side effects can occur with Sotyktu ...

Mild side effects that have been reported in people using Tazorac for plaque psoriasis include: In most cases, these side effects should be temporary, and some may be easily managed. But if you ...

BURLINGAME, CA, UNITED STATES, January 27, 2025 /EINPresswire / -- The worldwide "Plaque Psoriasis market" 2025 Research Report presents a professional and complete analysis of the Global Plaque ...